Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-05Clinical Trial Update: Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole [Phase 3]
Phase 3 trial comparing fulvestrant plus anastrozole versus anastrozole alone in breast cancer reported terminated with results posted.
-
CLINICAL_TRIALS research · 2019-04-05Clinical Trial Update: Patient-Assisted Compression in 3D - Impact on Image Quality and Workflow [NA]
Clinical trial updating patient-assisted compression in 3D imaging and its impact on image quality and workflow has completed with posted re…
-
CLINICAL_TRIALS trial_result · 2019-04-03Clinical Trial Update: Community Hospital Identification of High CV Risk Patients During Cancer Treatment [NA]
A terminated clinical trial at Wake Forest identified high cardiovascular risk patients during breast cancer treatment; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: A Study of Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer [Phase 3]
Phase 3 trial update assessing participant satisfaction and safety with subcutaneously administered trastuzumab (Herceptin) in HER2-positive…
-
FDA approval · 2019-04-01FDA Approved: DOCETAXEL — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for Docetaxel from Dr. Reddy's Laboratories Inc., authorizing the generic product under the approved…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients [Phase 1, Phase 2]
Phase 1/2 trial assessing safety, tolerability, and efficacy of AZD5363 combined with paclitaxel in advanced/metastatic breast cancer (ER-po…
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue [EARLY_Phase 1]
Early-phase trial evaluating whether conjugated linoleic acid (CLA) supplementation can modulate lipogenic pathways in breast cancer tissue;…
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis [Phase 4]
Phase 4 open-label study in postmenopausal women with estrogen receptor–positive locally advanced or metastatic breast cancer evaluating eve…
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 dose-escalation trial of PF-06650808 in advanced solid tumors; terminated with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer [Phase 3]
A Phase 3 trial comparing dose-adjusted adjuvant FEC to standard FEC for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Partial Breast Irradiation With Chemotherapy [Phase 1, Phase 2]
Phase 1/2 trial evaluating partial breast irradiation with chemotherapy for breast cancer; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy [Phase 3]
Phase 3 trial update for F-627 in women with breast cancer undergoing myelotoxic chemotherapy; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Cabergoline in Metastatic Breast Cancer [EARLY_Phase 1]
Early-phase trial updates the clinical trial of cabergoline in recurrent/metastatic breast cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2019-03-25Clinical Trial Update: A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064) [Phase 2]
Phase II trial evaluating ridaforolimus with exemestane versus ridaforolimus, dalotuzumab, and exemestane in breast cancer was completed wit…
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO) [Phase 1, Phase 2]
Clinical trial update for PIQHASSO evaluating PQR309 and eribulin in metastatic breast cancer across phase 1 and phase 2 (completed).
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery [Phase 1, Phase 2]
A clinical trial update for TAHP in HER2-positive breast cancer undergoing adjuvant therapy after surgery, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: High Dose Vitamin D vs Standard Dose Vitamin D Study [Phase 2]
Phase 2 trial comparing high-dose versus standard-dose vitamin D in breast cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 Mutation [Phase 2]
Phase 2 trial investigating pembrolizumab in combination with tamoxifen for advanced hormone receptor-positive breast cancer with ESR1 mutat…
-
CLINICAL_TRIALS trial_result · 2019-03-15Clinical Trial Update: Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC [Phase 2]
Phase 2 clinical trial evaluating pyrotinib in combination with docetaxel as first-line treatment for HER2-positive metastatic breast cancer…
-
CLINICAL_TRIALS trial_result · 2019-03-15Clinical Trial Update: A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer [Phase 1]
Phase 1 trial evaluating PF-03084014 in combination with docetaxel in advanced/metastatic breast cancer; study terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2019-03-13Clinical Trial Update: Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating Herceptin for efficacy in HER2-negative breast cancer with circulating tumor cells.
-
FDA approval · 2019-03-13FDA Approved: DOCETAXEL ANHYDROUS — Supplemental Application (Meitheal Pharmaceuticals Inc)
The FDA approved a supplemental application from Meitheal Pharmaceuticals to market docetaxel anhydrous as a generic chemotherapy drug.
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) [Phase 3]
The document provides an update on the Phase 3 TAILORx trial evaluating whether adding combination chemotherapy to hormone therapy improves …
-
CLINICAL_TRIALS trial_result · 2019-03-12Clinical Trial Update: Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating cyclophosphamide and vaccine therapy with or without trastuzumab in metastatic breast cancer; study completed with …
-
FDA approval · 2019-03-11FDA Approved: FASLODEX — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Faslodex (fulvestrant) submitted by AstraZeneca Pharmaceuticals LP, authorizing changes to i…